Gupta: There Will Be Vaccine Hesitancy After Blood Clot Reporting Related to J&J Vaccines

EXCERPT:

GUPTA: "Yeah, I think — you know, what I keep saying is that this should give you some confidence that the vaccines like Moderna and Pfizer are getting tens of millions of doses out there, have not had these even 1 in a million sort of safety concerns. So hopefully that actually builds your confidence at least around those two. But I’m not so naive to think, Jake, that even with the 1 in a million, with the J&J concern, that it may fuel some vaccine hesitancy. We saw that with AstraZeneca in Europe. I mean, there’s some surveys that say in France, for example, only 20% of people are willing to take the AstraZeneca vaccine. So there will be some vaccine hesitancy, I think, as a result of this towards the J&J vaccine, but hopefully we keep talking about it and it doesn’t translate to vaccines overall."